These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25466201)
1. Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers. Gund M; Khanna A; Dubash N; Damre A; Singh KS; Satyam A Bioorg Med Chem Lett; 2015 Jan; 25(1):122-7. PubMed ID: 25466201 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity. Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893 [TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorption. Li Y; Yang M; Zhao Y; Li L; Xu W Eur J Med Chem; 2021 Apr; 215():113276. PubMed ID: 33611186 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release. Yuan L; Chen W; Hu J; Zhang JZ; Yang D Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889 [TBL] [Abstract][Full Text] [Related]
5. Modulating paclitaxel bioavailability for targeting prostate cancer. Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149 [TBL] [Abstract][Full Text] [Related]
6. Polymerizable disulfide paclitaxel prodrug for controlled drug delivery. Ding Y; Chen W; Hu J; Du M; Yang D Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():386-90. PubMed ID: 25280719 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs. Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233 [TBL] [Abstract][Full Text] [Related]
8. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer. Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051 [TBL] [Abstract][Full Text] [Related]
9. Mutual prodrugs containing bio-cleavable and drug releasable disulfide linkers. Jain AK; Gund MG; Desai DC; Borhade N; Senthilkumar SP; Dhiman M; Mangu NK; Mali SV; Dubash NP; Halder S; Satyam A Bioorg Chem; 2013 Aug; 49():40-8. PubMed ID: 23886697 [TBL] [Abstract][Full Text] [Related]
10. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. Arpicco S; Stella B; Schiavon O; Milla P; Zonari D; Cattel L Int J Pharm; 2013 Oct; 454(2):653-9. PubMed ID: 23701999 [TBL] [Abstract][Full Text] [Related]
12. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel. Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140 [TBL] [Abstract][Full Text] [Related]
13. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage. Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064 [TBL] [Abstract][Full Text] [Related]
14. Development of protein-binding bifunctional linkers for a new generation of dual-acting prodrugs. Abu Ajaj K; Biniossek ML; Kratz F Bioconjug Chem; 2009 Feb; 20(2):390-6. PubMed ID: 19199576 [TBL] [Abstract][Full Text] [Related]
15. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents. Devkota L; Lin CM; Strecker TE; Wang Y; Tidmore JK; Chen Z; Guddneppanavar R; Jelinek CJ; Lopez R; Liu L; Hamel E; Mason RP; Chaplin DJ; Trawick ML; Pinney KG Bioorg Med Chem; 2016 Mar; 24(5):938-956. PubMed ID: 26852340 [TBL] [Abstract][Full Text] [Related]
17. Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs. Noguchi M; Skwarczynski M; Prakash H; Hirota S; Kimura T; Hayashi Y; Kiso Y Bioorg Med Chem; 2008 May; 16(10):5389-97. PubMed ID: 18440235 [TBL] [Abstract][Full Text] [Related]
18. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities. Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034 [TBL] [Abstract][Full Text] [Related]